chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left sided groin pain; Left sided lower abdominal pain; muscle pain in his back; This spontaneous case was reported by a patient and describes the occurrence of GROIN PAIN (Left sided groin pain), ABDOMINAL PAIN LOWER (Left sided lower abdominal pain) and BACK PAIN (muscle pain in his back) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012M20A) for COVID-19 vaccination.    Co-suspect product included non-company product PROPRANOLOL for an unknown indication.    The patient's past medical history included Colitis. Concomitant products included CALCIUM, FOLIC ACID, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), AMLODIPINE, ATORVASTATIN and PLANTAGO OVATA (METAMUCIL [PLANTAGO OVATA]) for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started PROPRANOLOL (unknown route) at an unspecified dose. On 12-Mar-2021, the patient experienced GROIN PAIN (Left sided groin pain), ABDOMINAL PAIN LOWER (Left sided lower abdominal pain) and BACK PAIN (muscle pain in his back). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, GROIN PAIN (Left sided groin pain), ABDOMINAL PAIN LOWER (Left sided lower abdominal pain) and BACK PAIN (muscle pain in his back) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.
10 hours after receiving vaccine, noticed reddened area where vaccine was administered. Next day later temp 100.5. Went to ED. Was dx with cellulitis and given clindamycin.
I am breastfeeding my 6 week old baby and after receiving Pfizer, my milk supply decreased a lot. I?m scared to receive second dose as my dr advised me my milk supply may completely dry up.   Due for second dose September 1,2021
mild scleroderma flare up on skin; mild headache; tiredness; joint swelling and pain; joint swelling and pain; mild connective tissue inflammation; This is a spontaneous report from a contactable consumer (Patient). A 49-years-old female (non pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: ER8727), dose 1 via an unspecified route of administration, administered in Arm Left on 23Mar2021 (at the age of 49-years-old) as SINGLE DOSE for covid-19 immunization. On an unspecified date medical history included scleroderma, scleroderma - symptoms of CREST syndrome(25+ years), food allergy to peanuts, shellfish. Concomitant medication(s) included loratadine (CLARITINE)and Multivitamin taken for an unspecified indication, on an unspecified date. On 23Mar2021, the patient experienced mild scleroderma flare up on skin, mild headache, tiredness, joint swelling and pain, joint swelling and pain and mild connective tissue inflammation. The outcome of the events were recovering.
patient felt faint, skin color turned white. patient complained she could not see or hear anything and she felt weak. we assisted patient back into our immunization, placed her on the floor, elevated her feet, and placed a pillow under her head. called 911. within 5 minutes the patient's color was returning to her face and she was able to see and hear again. it appears the patient had an anxiety attack as a result of the immunization.
blood in urine; This spontaneous case was reported by a patient and describes the occurrence of BLOOD URINE PRESENT (blood in urine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (blood in urine). At the time of the report, BLOOD URINE PRESENT (blood in urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO CONCOMITANT AND TREATMENT DRUGS WERE USED
Red flare reaction with edema rapidly increasing of swelling 2x2 1/2 area at site of Prevnar vaccination. Receeding by 1/2cm by 10 min post vaccine.
8 year old patient was administered the 0.3ml (30mcg) dose of the covid Pfizer vaccine inadvertently, no adverse effects noted at time of reporting
Information has been received from a consumer concerning her 50 year old husband with drug reactions/allergies to penicillin, sulfa and MINOCIN who on 23-FEB-2011 was vaccinated with a dose of PNEUMOVAX 23 (lot number not provided). The patient's wife reported that on 23-FEB-2011 evening, her husband experienced his right arm swelled at the injection site and on his entire arm and turned bright red, was hot to the touch, and was diagnosed as cellulitis. He developed fever and chills and felt like had pneumonia in his lungs as he had pneumonia previously. His physician prescribed BIAXIN. No lab diagnostic studies were performed. At the time of the report the patient had not recovered. Follow up information was received from the familiar nurse practitioner, indicated that the printer patient, with no birth defects and no other medical condition and no illness at the time of vaccination or adverse events following prior vaccination, received PNEUMOVAX 23on 23-FEB-2011, approximately late pm, into the right deltoid and on 24-FEB-2011. The patient called complained of high redness and swelling at site. The physician said that the patient was told apply cool soaks and appointment to 25-FEB-2011. The physician diagnosed adverse reaction to injection and cellulitis. It was also reported that the patient felt like had pneumonia and was placed on BIAXIN 500mg BID for 7 days and cool soaks and ALEVE pm. The physician stated that the next appointment was on 01-MAR-2011. On an unspecified date the patient recovered. Additional information is not expected.
@ ~5 min felt cotton mouth.  Got up to ask if he could go early.  Then at 10 min post injection, felt eyes feeling weird and he felt "high".   As in lightheaded.  @ 10 min, skin surrounding the eyes are puffy.  Given 25 mf benedryl.  No immediate SOB or wheeze. No lip or mouth or throat swelling.  Taken to ED.  Given IM epi 1:1000 0.3ml.  Pepcid and more benedryll PO.
Information was received on 20-APR-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. It is being complained and alleged that the patient was inoculated with a dose of ZOSTAVAX vaccine on or about 09-JAN-2009 by a physician as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 06-FEB-2014, the patient was treated by the physician for a painful rash that was diagnosed as shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Having tingling sensation in fingertips, fingernails; general weakness in the arms; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in the left arm on 27Jan2021 (at the age of 45-year-old) as single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications were not reported. On 28Jan2021, the patient experienced having tingling sensation in fingertips, fingernails and general weakness in the arms starting second day of initial dose. It has been almost 2 weeks since and symptoms not going away. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was reported as not resolved.  Follow-up attempts completed. No further information expected.
Severe muscle/joint pain/swelling in the middle of my left foot. Unable to walk in the morning. Slowly relieved over the next 36 hours.   Soreness at injection site. Relieved within 24 hrs of injection.
made me sick; Initial information received on 16-Nov-2021 regarding an unsolicited valid non-serious case from a consumer/ non-health care professional.  This case involves a patient (unknown age and gender) who was sick (illness), after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   Medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness, non-serious) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Took it once made me sick. Never again. Do they really think celebrities make us want to take these stupid shots."  It was unknown if the patient experienced any additional symptoms/ events.   It was unknown if there were laboratory data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
Site of injection became swollen, red, very tender (even to the touch of a shirt sleeve moving) and HOT.  This lasted until Sunday Evening.
11/27/07 had scratchy throat, coughing, the symptoms went to thrush, fever, high blood pressure, loss/slurred speech, loss of appetite, fatigue. I saw doctor on 12/5/07 gave me IV for dehydration sent me home. 12/6/07 Woke up seeing double vision, saw Ophthalmologist; went to ER - admitted for 6 days - diagnosed with Guillain Barre syndrome at hospital.  11/9/09 DC summary, hospital records recieved service dates 12/6/2007 to 12/12/2007. Assessment: 1. Miller Fisher varient of Guillain-Barre syndrome. 2. Hypertension. 3. Inability to close (L) eye or tear properly, dysarthria with nasal voice. Peripheral facial droop.   Sore throat past 9 days, oral thrush. Fatigue, slurred speech, unsteadiness walking, shuffling gate, and uncoordination. Patient admitted with symptoms of diplopia, palatable dysfunction, ataxia, and areflexia, along with non-reactive pupils. Reflexes absent/decreased. IVIG X 5 days. Tachycardia. Ambulates with walker.
Pericarditis Tamponade.  She went to the hospital with chest discomfort on the 25th and by the evening of the 26th had pericarditis to a degree that required a Pericardial Window emergency procedure.  Prior to the vaccine, she was doing great with no issues.  She was put on a ventilator and came through the procedure on the 27th.  She was moved to rehab on February 1st, which is where she remains as of this submission.
Client stated she felt dizzy after receiving her vaccine.  Vital signs are BP 151/93, HR 81, O2 sat 97%. Client states she feels better. Discharged home by EMS.
- Has pain directly on vertebra. Located a little bit above the waist and up to the shoulders. - Left side of back also hurts. Right side is ok. - Denies HA. - Talking and acting normally. - When he looks up, touches chin to chest and looks over shoulders, the pain worsens. Worst pain is when looking over right shoulder. - Still eating and attending online classes like normal. - He could not sleep well last night because of the pain. - No fever.  - Walking normally but had to look down a little bit d/t pain.  - When he sits down, he needs to sit forward and can't straighten his back, but mom wondering if that is because he's been sitting for a while for school. - Pt reports he is urinating normally and had a normal BM today - The left hand has a little bit of pain and discomfort and some numbness on his legs but he has been sitting for a long time doing his online school. (pt did not volunteer this information but was provided when mom directly asked about any numbness/tingling.) TREATMENT: - Increase fluids - Get plenty of rest - Alternate Tylenol / Ibuprofen every 3-4 hours as needed for pain - If symptoms drastically worsen or a high fever is present then please be sure to take the child to the ER
Nausea  5-7hs after the shot; vomiting 5-7hs after the shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea  5-7hs after the shot) and VOMITING (vomiting 5-7hs after the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea  5-7hs after the shot) and VOMITING (vomiting 5-7hs after the shot). At the time of the report, NAUSEA (Nausea  5-7hs after the shot) and VOMITING (vomiting 5-7hs after the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Pt received TDaP vaccine during PCP appointment on 4/21. Shortly after receiving vaccination, patient began to notice rash on his face and trunk. Pt took OTC diphenhydramine at home w/o any improvement in rash. Pt then presented to urgent care on 4/27/17 for evaluation of rash and received KENALOG IM x 1, Medrol dose pack, diphenhydramine, and ranitidine.
PT complains of not being able to move her arm, pain from her shoulder to her hand, swelling in the hand, and discoloration compared to the other hand
From shoulder to elbow swollen, red, and hot; general maliase, hives the next day, increased lymph nodes (possibly related).
The next 2 day 12-23 and 12-24 I experienced: Extreme lethargy (Had to go back to sleep after 6 hours). This was after a full 8 hours rest. Chills with uncontrolled shaking, Fever, Entire deltoid swollen and slightly painful when touched. Was hard to move arm. Slight muscle weakness. 12-25 and 12-26: Still abnormally lethargic, but had about 80 percent of my energy back. Arm still fully swollen. All other symptoms gone. 12-27: Returned to work after holiday and was still had some lethargy. Had a dizzy spell halfway through 8 hour shift. Drank water and took aspirin. Recovered to a dulling headache for the evening until I went to sleep at 9:00 PM. Arm less swollen and not as painful when touched. 12-30: Same amount of lethargy. Arm no longer swollen and painful. Bicep brachii and brachioradialis muscles have continuous non painful twitching. Never experienced this before. 1-3 (Today): Still same amount of lethargy. Same amount of muscle twitching.
Psychological and emotional disturbances. Menstrual changes (very sudden). Seems to be hormonal
At about 11 pm on 3/26/21, patient experienced uncontrollable chills.  He did not sleep well.  On 3/27/21, he got a fever that ranged between 99.7 to 102.6.  He could not eat and thinking about it made his stomach upset.  Every bone and joint in his body ached, even his skin hurt and he had a bad headache.  Tylenol did little to alleviate any of these symptoms.  His fever  broke on 3/27/21 about 11 pm.  He still did not sleep well and slept until noon on 3/28/21.  His symptoms persisted except for the fever, though he still had chills that night.  He still did not feel well throughout 3/29/21 and 3/30/21 and he still ate very, very little until 3/31/21.  On 3/31/21, he was able to eat and went to the grocery, but it wiped him out and he slept for a couple of hours in the afternoon.  He still has a dull headache and very little energy that is keeping him from doing his daily activities.
Administered expired vaccineHasn't expired from manufacturer expiration but was in fridge over 30 days; Vaccine administered to patient after 30 days of storage in fridge; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccineHasn't expired from manufacturer expiration but was in fridge over 30 days), PRODUCT STORAGE ERROR (Vaccine administered to patient after 30 days of storage in fridge) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 201L228) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccineHasn't expired from manufacturer expiration but was in fridge over 30 days), PRODUCT STORAGE ERROR (Vaccine administered to patient after 30 days of storage in fridge) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccineHasn't expired from manufacturer expiration but was in fridge over 30 days), PRODUCT STORAGE ERROR (Vaccine administered to patient after 30 days of storage in fridge) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered expired vaccineHasn't expired from manufacturer expiration but was in fridge over 30 days) and PRODUCT STORAGE ERROR (Vaccine administered to patient after 30 days of storage in fridge).    Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.
Received YF, MMR and Hep-B on 4/3/01 and pt reports that on 4/6/01, he felt fatigued and light-headed. He complained of low back pain. In the office he was noted to have a fine rash on arms and macular rash in clusters on both legs. Red, raised blister-like sore on right buccal mucosa. Temperature was 98.8F in the office with fine red, rash on both cheeks.
Patient with pericarditis finding on echocardiogram done in August. Unknown onset, pt had started wearing a watch and saw that her HR was elevated. She states she became aware of rapid HR and became worried about it when it was over 150 so went to ER, had normal initial work up, after eval here and cardiology referral the pericarditis was found, so onset time is unknown.
Resident was given COVID booster 2 weeks before it was due.  No reactions or symptoms were detected.
ELEVATED TEMP, HEADACHE, NECK PAIN, BACK PAIN, VOMITING, GENERAL MALAISE. ON 07/08/2016, PATIENT WAS EVALUATED IN THE CLINIC AND HER TEMP WAS 101.4 F. SHE WAS HAVING MILD HEADACHE, BUT NECK PAIN AND BACK PAIN WERE GONE. PHYSICAL EXAM WAS NEGATIVE FOR ACUTE INFECTION, THEN SHE RECEIVED BENADRYL 25MG INJECTION AND ORAL TYLENOL. SHE WAS DISCHARGED HOME WITH A PRESCRIPTION OF ORAL PREDNISONE 10MG TO TAKE FOR FIVE DAYS AND INSTRUCTIONS TO CONTINUE BENADRYL 25MG EVERY 8 HRS FOR 3 DAYS.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 26-MAY-2016 the patient was vaccinated with an improperly stored dose of GARDASIL 9 0.5ml (lot # L038917, expiration date 20-FEB-2018, route unspecified). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time for the first time was 72 hours with the lowest recorded temperature of 32 Fahrenheit degree. The total cumulative excursion time of the second time was 144 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Itching, gave Benadryl.   Pt improved within 10 min.
Pain with swallowing; Stinging pain/ soreness in top right soft palate of mouth; Nausea; Extreme cold for minutes after the nausea; Excess sweating for minutes after the nausea; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02May2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included mild allergy to shrimp and coconut oil. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. On 02May2021, the patient experienced nausea for first few minutes of vaccine and extreme cold and excess sweating for minutes after the nausea. On 05May2021, the patient currently experiencing stinging pain or soreness in top right soft palate of mouth. Pain with swallowing that has persisted for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, extreme cold, excess sweating and stinging pain or soreness in top right soft palate of mouth were unknown at the time of this report. The clinical outcome of the event pain with swallowing was resolved on an unknown date in May2021, after the duration of 3 days.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Fever, redness, swelling in the arm, pain, muscle aches chills, sore joins, headache (symptoms lasted four days). Swelling in the arm and redness spread to a very large area. With very high fever in the arm. Continued for more than a week I just took TYLENOL.